Mirae Asset Global Investments Co., Ltd. Natera, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Natera, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 59,808 shares of NTRA stock, worth $10.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
59,808
Previous 56,971
4.98%
Holding current value
$10.8 Million
Previous $8.06 Million
25.41%
% of portfolio
0.04%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding NTRA
# of Institutions
704Shares Held
125MCall Options Held
590KPut Options Held
246K-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.29 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$2.2 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.33 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.22 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.82MShares$871 Million3.66% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $17.5B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...